Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
positive publishing date : 2021 - 10 - 04 save search
MuleSoft Positioned as a Leader Again in the Gartner® Magic Quadrant™ for Enterprise Integration Platform as a Service and the Magic Quadrant for Full Life Cycle API Management
Published: 2021-10-04 (Crawled : 17:00) - prnewswire.com
CRM M | $276.19 -0.18% -1.08% 3.9M
|
Technology Services
|
| O: -0.01%
H: 0.03%
C: -1.58%
IT | $451.06 0.18% 0.0% 280K
|
Commercial Services
|
| O: -0.43%
H: 1.58%
C: 0.08%
integration positive
Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union
Published: 2021-10-04 (Crawled : 17:00) - globenewswire.com
SNY | News | $46.66 -2.16% -2.21% 1.7M
|
Health Technology
|
| O: 0.54%
H: 0.77%
C: 0.17%
BNTX | News | $88.18 -0.35% -0.35% 280K
|
Health Technology
|
| O: -7.79%
H: 7.42%
C: 5.95%
covid europe positive vaccine chmp covid-19
Agile Therapeutics Announces Addition of Twirla® to a Preferred Drug Position on Medi-Cal FormularyLargest Medicaid program in the U.S. adds Twirla to Preferred Drug List as of October 1, 2021
Published: 2021-10-04 (Crawled : 15:00) - biospace.com/
AGRX | $0.37 0.0% 95K
|
Health Technology
|
| O: 0.0%
H: 4.04%
C: 0.0%
drug twirla
Acurx Presents Positive Ibezapolstat Microbiome Data from Its Phase 2a Trial at IDWeek
Published: 2021-10-04 (Crawled : 14:00) - biospace.com/
ACXP | $2.04 -2.29% 17K
|
Professional, Scientific, and T...
|
| O: -9.31%
H: 9.42%
C: -1.38%
phase 2 positive trial phase 2b
Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients with NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted grant designation
Zai Lab Partner Turning Point Therapeutics Granted Breakthrough Therapy Designation for Repotrectinib Treatment in Patients With NTRK-Positive, TKI-Pretreated Advanced Solid Tumors
Published: 2021-10-04 (Crawled : 13:15) - globenewswire.com
ZLAB | $15.66 3.57% 3.45% 430K
|
Health Technology
|
| O: -4.58%
H: 2.65%
C: 0.49%
TPTX | $76.01 -0.03%
|
Health Technology
|
| O: -0.53%
H: 2.39%
C: -0.01%
treatment solid tumors positive therapy breakthrough therapy granted designation
PDS Biotech Enrolls First Stage of Checkpoint Inhibitor Naïve Patient Arm of Phase 2 Clinical Trial in Advanced HPV-16 Positive Head and Neck Cancer
Published: 2021-10-04 (Crawled : 13:00) - globenewswire.com
PDSB | $3.26 1.88% 1.84% 450K
|
Health Technology
|
| O: -4.78%
H: 2.41%
C: 0.0%
phase 2 positive hpv cancer biotech iot trial enroll
OpGen Provides Business Update and Announces Preliminary Unaudited Revenue and Cash Position for Third Quarter 2021
Published: 2021-10-04 (Crawled : 12:00) - globenewswire.com
OPGN | $0.581 -5.22% -5.51% 170K
|
Commercial Services
|
| O: 24.37%
H: 2.31%
C: -15.27%
positive
Berry Corporation (bry) Positioned to Be a Leader in California’s Well Abandonment and Fugitive Emission Reduction Efforts
Published: 2021-10-04 (Crawled : 11:00) - globenewswire.com
BRY | $8.62 -0.69% -0.7% 940K
|
Energy Minerals
|
| O: 5.19%
H: 5.6%
C: -0.4%
positive
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.